إعلان
إعلان

SNY

SNY logo

Sanofi - ADR

48.37
USD
برعاية
+0.20
+0.42%
٠٧ يناير, ١٦:٠٠ UTC -5
مغلق
exchange

بعد الإغلاق

48.44

+0.07
+0.14%

تقارير أرباح SNY

النسبة الإيجابية المفاجئة

SNY تفوق 30 من 39 آخر التقديرات.

77%

التقرير التالي

بيانات التقرير القادم
٢٩ يناير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$11.41B
/
$1.42
التغير الضمني من Q3 25 (Revenue/ EPS)
-8.24%
/
-51.20%
التغير الضمني من Q4 24 (Revenue/ EPS)
+8.01%
/
+8.40%

Sanofi - ADR earnings per share and revenue

On ٢٤ أكتوبر ٢٠٢٥, SNY reported earnings of 2.91 USD per share (EPS) for Q3 25, beating the estimate of 2.74 USD, resulting in a 5.86% surprise. Revenue reached 12.43 مليار, compared to an expected 12.60 مليار, with a -1.31% difference. The market reacted with a +4.28% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 8 المحللين forecast an EPS of 1.42 USD, with revenue projected to reach 11.41 مليار USD, implying an نقصان of -51.20% EPS, and نقصان of -8.24% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, Sanofi - ADR reported EPS of $2.91, beating estimates by 5.86%, and revenue of $12.43B, -1.31% below expectations.
The stock price moved up 4.28%, changed from $49.52 before the earnings release to $51.64 the day after.
The next earning report is scheduled for ٢٩ يناير ٢٠٢٦.
Based on 8 المحللين, Sanofi - ADR is expected to report EPS of $1.42 and revenue of $11.41B for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان